Anthony Dragovich, MD
Pain Medicine · Salem, VANPI 1134236763
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 597 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 46 manufacturers reported payments, led by Medtronic at 58.4% of the total. Among pain medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 597 payments — averaging $25.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Boston Scientific$1K
- AbbVie$1K
- Pfizer$460
- Collegium Pharmaceutical, Inc.$453
- Abbott$438
- plus $3K from 40 others
What the payments were for
- Food & beverage$15,424100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,686
- INTELLIS$1,143
- SYNCHROMEDII$454
- Accurian$262
- VANTA ADAPTIVESTIM$245
- INCEPTIV$160
- Intracept$150
- OSTEOCOOL RF ABLATION$129
- SYNCHROMED$126
- PROCLAIM$119
- RESTORE$116
- KYPHON Balloon Kyphoplasty$115
- Superion Indirect Decompression System$108
- AUTOFILL$108
- KYPHON EXPRESS II KYPHOPAK TRAY$101
How this compares
$15,454 in reported general payments places this provider in the 90th percentile of 150 pain medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 87 | $85,969 |
| BotoxOnabotulinumtoxina | 60 | $78,991 |
| Nurtec OdtRimegepant Sulfate | 45 | $73,591 |
| UbrelvyUbrogepant | 31 | $65,273 |
| BelbucaBuprenorphine Hcl | 65 | $64,436 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,473 | $41,214 |
| Oxycodone Hcl | 1,367 | $34,427 |
| Nucynta ErTapentadol Hcl | 15 | $34,054 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 949 | $33,835 |
| Buprenorphine | 121 | $29,801 |
| OxycontinOxycodone Hcl | 36 | $21,262 |
| Fentanyl | 128 | $15,228 |
| LinzessLinaclotide | 29 | $15,220 |
| Morphine Sulfate ErMorphine Sulfate | 223 | $11,819 |
| MovantikNaloxegol Oxalate | 23 | $9,091 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta Er | $453 | $184,459167 claims |
| AbbVieBotox, Ubrelvy, Linzess | $1,008 | $159,484120 claims |
| PfizerNurtec Odt | $460 | $73,59145 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $12 | $31,538176 claims |
| MerckBelsomra | $60 | $7,42815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 150 pain medicine providers in Virginia.
Other pain medicine in Salem
- George BaylorSalem$24K
- Marc SwansonSalem$8K
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
- Lynn KohanCharlottesville$30K
- Jasmit BrarLansdowne$18K
- Christina ShinCharlottesville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.